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Transfemoral endovascular repair of abdominal
aortic aneurysms (AAAs) has proven feasibility and
considerable benefits over traditional open repair.1-3
However, strict anatomic requirements have limited
the application of this method of therapy. Indeed,
several recent studies suggest that only 10% to 20%
of all AAAs are treatable with currently available
commercial devices.4-6 Although inadequate proxi-
mal aortic neck length and diameter are generally
thought to be the main limitations in endograft
placement, adverse iliac anatomy precludes place-
ment in as many as 50% of patients.5 The use of an
aortouniiliac endoprosthesis in combination with a
femorofemoral crossover graft would permit an
endovascular approach to the broadest array of
patients as only one iliac system is required to satis-
fy anatomic criteria (Fig 1, A). However, enthusiasm
for this type of reconstruction has been restrained by
apprehension regarding the durability of the femo-
rofemoral bypass graft and the potential for late
complications such as graft infection or pseudoa-
neurysm formation. Furthermore, the consequences
of exclusion of one or both internal iliac arteries
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Objective: The purpose of this study was to determine the early efficacy of endovascular
aortouniiliac stent grafts with femorofemoral bypass graft in the treatment of aortoiliac
aneurysmal disease.
Methods: We analyzed 51 consecutive patients from January 1997 to March 1999 with a
mean follow-up of 15.8 months. Patients ranged in age from 44 to 93 years (mean, 75
years) with a mean aortic aneurysm diameter of 6.2 cm. Technical success was achieved
in 50 patients; one patient required conversion to open repair intraoperatively. We placed
28 custom-made and 22 commercial devices. The mean operative time was 223 minutes.
The endograft was extended to the external iliac artery in 42% of cases. The contralat-
eral common iliac artery was occluded using either a closed covered stent or intralumi-
nal coils.
Results: The median hospital stay was 4 days with an average intensive care unit stay of
0.25 days. There were no operative mortalities. Two patients died during follow-up
from unrelated conditions. Endoleaks occurred in 11 patients (22%); seven patients
(14%) required intervention (four catheter based, three operative). Other complications
occurred in 38% of patients but were largely remote or wound related. One femoro-
femoral bypass graft occluded immediately postoperatively as a result of an intraproce-
dural external iliac dissection yielding a 98% primary patency and 100% secondary paten-
cy. Clinical success was achieved in 88% of patients.
Conclusions: These data suggest that this strategy represents a reliable method of repair
of aortoiliac aneurysmal disease and extends the capability of an endoluminal approach
to patients with complex iliac anatomy. (J Vasc Surg 2000;31:1135-41.)
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occasionally required by this repair may be signifi-
cant. Therefore, the purpose of this study was to
analyze the results of endovascular aortouniiliac
bypass graft with concomitant femorofemoral bypass
graft in patients with aortoiliac aneurysmal disease. 
METHODS
From January 1997 to March 1999 we analyzed
51 consecutive patients undergoing transfemoral
endovascular aortouniiliac graft with femorofemoral
bypass graft and contralateral iliac occlusion for aor-
toiliac aneurysmal disease. All patients underwent
contrast-enhanced spiral computed tomography
(CT) with 3.0-mm cuts. Subsequently, all patients
had biplanar contrast angiography with radiopaque-
measuring catheters to allow precise measurements
for the endoprosthesis. Anatomic selection criteria
used for endovascular repair have been previously
described from our institution.1 In general, the cri-
teria for aortouniiliac grafts are somewhat more
lenient, because only one suitable iliac artery is
required to meet anatomic criteria. For this study,
we required one distal common iliac artery or exter-
nal iliac artery to have an appropriate attachment site
of 1.5 cm in length and 14 mm or less in diameter.
In cases requiring extension of the aortouniiliac
endograft to the external iliac artery level, the inter-
nal iliac artery ipsilateral to the planned aortouniili-
ac graft was occluded with coil embolization preop-
eratively. The protocol for endovascular repair of
AAA was approved by the institutional review board
of the Massachusetts General Hospital. 
All procedures were performed in an operating
room environment by a team of vascular surgeons
and interventional radiologists. The choice of anes-
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Table I. Patient comorbidity
Characteristic No. of patients (%)
Hypertension 34 (68)
Current tobacco use 13 (26)
Diabetes mellitus 5 (10)
COPD 15 (30)
Cardiac disease 31 (62)
Congestive heart failure 9 (18)
Creatinine level > 1.6 mg/dL 5 (10)
Peripheral vascular disease 19 (38)
COPD, Chronic obstructive pulmonary disease.
Fig 1. A, Schematic depicting aortouniiliac endograft with contralateral common iliac exclusion and
femorofemoral bypass graft. B, Standard intraoperative completion angiogram of aortouniiliac endo-
graft. C, Angiogram demonstrating femorofemoral graft with retrograde filling of external and internal
iliac arteries contralateral to the aortouniiliac endograft.
A B C
thetic was made by the anesthetist in consultation
with the vascular surgeon. Accurate endograft
deployment and positioning, as well as the absence
of endoleaks, were confirmed by intraoperative aor-
tography (Fig 1). All patients had a plain abdominal
radiograph and a contrast enhanced CT scan of the
abdomen on the first postoperative day to establish
a baseline study, confirm placement, and evaluate for
endoleaks. Physical examination, abdominal radiog-
raphy, and CT scans were obtained at 6 months, 12
months, and once a year thereafter.
Complications were recorded as both local/vas-
cular and systemic/remote, as suggested by the Ad
Hoc Committee for Standardizing Reporting
Practices in Vascular Surgery of the Society for
Vascular Surgery and International Society for
Cardiovascular Surgery.7 If two or more complica-
tions occurred in the same patient, only the most
significant complication was recorded to avoid
duplication. Where applicable, nominal data are pre-
sented as mean ± SE of the mean. 
RESULTS
The average patient in this study was male (94%)
and was aged 75.2 ± 1.2 years (range, 44-93 years).
The mean aortic aneurysm diameter was 6.2 cm. As
shown in Table I, patients in the study had a stan-
dard comorbidity for those undergoing vascular
interventions. Technical success was achieved in 50
patients; one patient required conversion to open
repair intraoperatively. Of these, 22 patients received
a commercial device (EVT-Guidant; Menlo Park,
Calif) as part of a United States Food and Drug
Administration Phase I and II trial. The remaining
patients received an endograft custom-made at our
institution of Gianturco stents and standard vascular
graft material, as previously described.1
A combination of continuous lumbar epidural
with general anesthesia was used in 28 patients
(56%). Eighteen patients underwent general anes-
thesia alone, and four procedures were performed
under epidural only. The mean operative time was
223 ± 8 minutes. The mean estimated blood loss
was 631 ± 62 mL. The aortoiliac graft was carried to
the external iliac artery in 42% of cases. The con-
tralateral iliac artery was occluded with a mean of 20
± 2 coils in 36 patients. The remaining arteries were
occluded with a commercial, closed, covered stent
(EVT-Guidant). In six patients (12%), both internal
iliac arteries were excluded. The femorofemoral
bypass graft was created with 8- or 10-mm diameter
grafts of Dacron (22) or polytetrafluoroethylene
(28) at the surgeons’ discretion.
The median inpatient hospital stay was 4.0 ± 1.2
days. Most patients (87.5%) were transferred direct-
ly to the hospital floor after a 4- to 6-hour stay in a
standard postoperative recovery room. Half of all
patients were discharged without anticoagulation.
Aspirin was administered to 21 patients (43%).
Three patients (7%) taking warfarin for preoperative
conditions had it resumed upon discharge. 
The mean follow-up was 15.8 months (range,
2.2-33 months) (Table II). There were no perioper-
ative deaths. Two patients died during follow-up
from unrelated conditions. Other complications
occurred in 38% of patients but were largely remote
or wound related (Table III). One groin wound
hematoma was seen that required operative
drainage. Three patients had groin wound infec-
tions; one required complicated skin flap closure.
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Table II. Life table analysis of cumulative patency
Patent, but withdrawn because of
Total Interval Cumulative 
Time No. at risk No. failed Duration Lost Death withdrawn patency patency SE
0 50 0 3 0 0 3 1.00 100 0
1 47 1 3 0 0 3 0.98 97.8 0.31
3 43 0 2 2 0 4 1.00 97.8 0.34
6 39 0 3 1 1 5 1.00 97.8 0.37
9 34 0 5 0 0 5 1.00 97.8 0.43
12 29 0 4 0 1 5 1.00 97.8 0.50
15 24 0 6 0 0 6 1.00 97.8 0.60
18 18 0 5 0 0 5 1.00 97.8 0.81
21 13 0 4 0 0 4 1.00 97.8 1.12
24 9 0 4 0 0 4 1.00 97.8 1.61
27 5 0 2 0 0 2 1.00 97.8 2.90
30 3 0 2 0 0 2 1.00 97.8 4.83
33 1 0 3 0 0 3 1.00 97.8 14.50
Two intraoperative arterial injuries were noted that
required immediate repair. Device kinking or steno-
sis that necessitated intervention occurred in four
patients (Fig 2). One stenosis resulted in aortoiliac
graft occlusion requiring lytic therapy and stent
placement. The remaining patients were treated with
secondary endovascular procedures (angioplasty and
stent placement). All of these occurred in the body
of an unsupported endograft. 
One femorofemoral bypass graft occluded imme-
diately postoperatively as a result of unrecognized
intraprocedural external iliac dissection. This required
placement of an iliofemoral interposition graft through
a secondary procedure, thus yielding a 98% primary
patency and 100% secondary patency of the femoro-
femoral bypass graft. Table II depicts a life table analy-
sis of cumulative (primary) patency. Ischemic colitis
was suspected on colonoscopy in one patient with
postoperative abdominal pain and diarrhea. This
patient responded to conservative therapy. Both inter-
nal iliac arteries were excluded in that patient. Pain or
discomfort in the hip and buttock area related to exer-
cise and suggestive of buttock claudication was noted
in 22% of patients in the first few postoperative weeks.
This complication generally improved over 2 to 3
months but persisted for the duration of the follow-up
interval in six patients (12%). Three of these patients
had one internal iliac artery preserved at the time of
their endograft placement. 
Systemic complications (Table III) were remark-
able for three patients with acute renal failure. One
of these patients required temporary dialysis while
hospitalized. Ninety percent of all patients in the
study had a baseline creatinine level of 1.6 mg/dL.
All patients with postoperative elevations in creati-
nine levels had a baseline creatinine level of 1.5
mg/dL. No patient required permanent dialysis. 
Endoleaks occurred in 11 patients (22%); seven
of these patients (14%) required intervention (four
catheter based, three operative). Type I endoleaks
occurred in 5 patients, 3 at the proximal attachment
site and 2 at the distal attachment site. Three of the
five required intervention. One of these patients
required open aortoiliac grafting for a persistent leak
with a contrast–filled, symptomatic aneurysm. The
other two were treated with coil embolization of the
sac. Two small Type I endoleaks sealed without
intervention in the initial 6 months after insertion.
Type II endoleaks were seen in six patients. Four of
these required intervention, two catheter based and
two open. Catheter-based interventions included
coil embolization of an enlarging aneurysm sac for a
lumbar-to-lumbar leak and coil embolization of a
persistent leak from a patent inferior mesenteric
artery. Of the open procedures, one patient under-
went late conversion to open graft repair for a large
persistent branch-to-branch leak and enlargement of
the aneurysm sac 4 months after endograft place-
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Fig 2. Endograft stenosis. A, Intraoperative angiogram showing stenosis of aortouniiliac endograft
resulting from a twist in redundant graft material distal to radiopaque marker (arrow) and proximal to
stent attachment site (curved arrow). B, Resolution of stenosis with secondary Wallstent deployment.
ment. The second patient required open ligation of
a contralateral external iliac artery to correct contin-
ued retrograde filling of a common iliac aneurysm
after failure to thrombose it with intraluminal coils.
This was the only leak directly related to the failure
of a contralateral iliac artery with coils. No failure
was noted from the commercial occluder. Clinical
failures (graft endoleaks persisting > 6 months or
aneurysm sac enlargement) occurred in six patients
(12%).7 No new late onset endoleaks were noted.
No late ruptures were seen. No evidence for stent
migration was found. Aneurysm sac shrinkage aver-
aged 1.2 cm over a mean CT interval of 15 months. 
DISCUSSION
Anatomic criteria for endovascular AAA treatment
generally have included a proximal aneurysm neck less
than 26 mm in diameter and 15 mm or more in
length, without calcification or significant angulation
(> 75 degrees). Distally, touchdown zones of 10 to 15
mm of aortic cuff (for the tube configuration) or 20
mm of nonaneurysmal iliac artery (for a bifurcated
graft) have been standard requirements in trial proto-
cols. Furthermore, the femoral and iliac vessels must
be of sufficient caliber to accept the introducer sheath
and have limited tortuosity. 
These relatively strict criteria have limited the
applicability of the endovascular approach in many
patients. In the initial phase I trial, Moore and
Rutherford4 reported that the endovascular tube graft
would be applicable in only 13% of all patients with
AAA. Other investigators have estimated that the per-
centage of AAA anatomically suitable to endovascular
tube graft repair is even less.6 More worrisome, how-
ever, is the existence of some evidence suggesting that
the tube graft configuration may have a higher failure
rate than either the bifurcated or aortouniiliac device.
In a study by May et al,8 the incidence of early and
late endoleaks was significantly higher in those
patients receiving a tube endograft. Kaplan-Meier
curves showed a probability of success in 50% of tube
grafts and 80% of nontube grafts. 
The introduction of bifurcated endoprostheses
was predicted to allow endovascular repair in a
greater number of patients with a higher degree of
success.9 In a review of 154 abdominal CT scans,
however, Armon et al6 found only six patients (4%)
suitable for an endovascular tube graft and 15
patients (10%) suitable for a bifurcated endoprosthe-
sis. Similarly, Balm et al10 described 18 patients
treatable by bifurcated endografts out of 66 CT
scans reviewed. In a subsequent clinical trial,
Treiman et al5 evaluated 164 consecutive patients
with AAA for endovascular grafting and found that
less than 20% of their patients were treatable with
devices available at that time. In this group, insuffi-
cient distal neck, iliac occlusive disease, or iliac
stenosis was the primary contraindication to an
endovascular approach in nearly 50% of the patients. 
It is likely that endovascular repair will be appro-
priate for a larger number of patients as the availability
of bifurcated, modular grafts becomes available.
However, even with the availability of such devices,
patients with complex pelvic aneurysmal disease will
remain challenging. The application of aortouniiliac
stent graft and cross-pelvic bypass graft may extend the
potential of an endoluminal repair to the patient with
complex or extensive pelvic aneurysmal disease who
might not otherwise be treated. Indeed, as many as
60% of all aneurysms may be treatable by this
approach.1,6 In the discussion of the Treiman paper,
the author concludes that as many as 40% of the
patients previously excluded would have been poten-
tial candidates for unilateral aortoiliac/femorofemoral
bypass grafting. The limitation of this approach has
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Table III. Complications in patients with aor-
touniiliac/femorofemoral bypass grafts
Complication No. of patients (%)
Local or vascular 14 (28)
Graft kinking/stenosis 3 (6)
Wound infection 3 (6)
Arterial injury 2 (4)
Graft thrombosis 2 (4)
Buttock claudication 1 (2)
Hematoma 1 (2)
Ischemic colitis 1 (2)
Systemic or remote 6 (12)
Acute renal failure (transient) 3 (6)
Bacteremia 1 (2)
Myocardial infarction 1 (2)
Urinary tract infection 1 (2)
Table IV. Reported patencies of isolated femoro-
femoral bypass grafts
Patency
Reference Year Patients 1 year (%) 5 year (%)
Perler23 1994 44 81* 59*
Schneider24 1994 91 60*†
Brener25 1993 228 55*
Criado26 1993 110 83* 60*
Dick27 1980 133 73.3‡
*Primary.
†Three-year data.
‡Cumulative.
principally been some reticence to the usage of the
femorofemoral bypass. Historically, 5-year primary
patency rates of femorofemoral grafts have been less
than aortobifemoral grafts, to which they are most
often compared. Recent studies reveal 5-year primary
patencies of the femorofemoral graft (placed for occlu-
sive disease) ranging from 55% to 73% (Table IV). In
our study, albeit with only 15.8-months’ follow-up, we
have found 98% primary patency. This compares favor-
ably with other recent studies and may be somewhat
higher (Table IV). Others have suggested that patency
of extra-anatomic grafts may vary depending on the
indication for bypass graft.11,12 Because most patients
with primary aneurysmal disease have intact runoff, an
extension of that hypothesis might suggest that femo-
rofemoral grafts placed for aneurysmal disease will
have overall higher patency than those placed for
occlusive disease. Our experience and those of several
other groups11,12 support that contention. Early stud-
ies of the aortouniiliac endograft with femorofemoral
bypass graft in the setting of occlusive disease have had
relatively good outcomes, although follow-up and
numbers are limited.13-15
In a recent review of early femorofemoral graft
complications after aortouniiliac endograft place-
ment, Walker et al16 followed up 136 patients over a
median follow-up of 7 months. They found an over-
all complication rate of 13% attributable solely to the
femorofemoral bypass graft. These included 2 infect-
ed grafts, 1 thrombosed graft, 1 pseudoaneurysm,
and 7 groin hematomas (3 of which required opera-
tive intervention). 
Clearly, the benefits of an endovascular approach
to AAA repair (such as decreased blood loss,
decreased use of intensive care units and earlier dis-
charge1) do not come freely. Complications occurred
in 38% of patients in our series. This is within the
range of those generally reported with endovascular
graft configurations of 10% to 50%.1-4,17 A recent
report by May et al18 describing their large experi-
ence with AAA repair also noted an adverse event
rate of 45%. Most complications in our series, how-
ever, did not significantly affect the clinical course or
outcome of patients. Graft kinking or stenosis was
noted in four of our patients, all in patients receiving
unsupported endografts. Only one of these resulted
in graft thrombosis, but all required secondary
endovascular interventions (stenting) for symptoms.
The incidence of endoleaks does not appear to be
higher with the aortouniiliac approach than with
other endovascular grafts.16,19-21
Because inferior mesenteric artery occlusion is
commonplace with aneurysmal disease and ensured
with endograft placement, the occlusion of one or
both hypogastric arteries associated with aortouniil-
iac grafting has raised the concern for the potential
of ischemic colitis. This was seen in one patient of
the six with bilateral hypogastric artery occlusion.
The patient had abdominal pain, leukocytosis, and
diarrhea. Colonoscopy indicated probable ischemic
colitis on the fifth postoperative day. The patient was
maintained on broad-spectrum antibiotics and
bowel rest and recovered uneventfully. Similar
events have been noted previously in endovascular
aortouniiliac grafting for both abdominal aortic and
iliac aneurysmal disease.21,22
CONCLUSION
Endovascular aortouniiliac grafting with con-
comitant femorofemoral bypass graft should allow
an endovascular approach to a broader range of
patients with abdominal aortic and aortoiliac
aneurysmal disease. This study suggests that effec-
tive aneurysm exclusion can be achieved with
acceptable morbidity using this strategy. The relative
aversion to the use of the femorofemoral bypass
graft required by this approach appears unfounded.
As with most studies in which enthusiasm is high
and follow-up is relatively limited, long-term analy-
sis will be required to confirm these early data. 
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